These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 12227872

  • 21. Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
    Relyveld GN, Kingswijk MM, Reitsma JB, Menke HE, Bos JD, Westerhof W.
    J Am Acad Dermatol; 2006 Nov; 55(5):836-43. PubMed ID: 17052490
    [Abstract] [Full Text] [Related]

  • 22. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
    Tanghetti E, Kircik L, Wilson D, Dhawan S.
    J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
    [Abstract] [Full Text] [Related]

  • 23. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.
    Okamoto K, Ikeda F, Kanayama S, Nakajima A, Matsumoto T, Ishii R, Umehara M, Gotoh N, Hayashi N, Iyoda T, Matsuzaki K, Matsumoto S, Kawashima M.
    J Infect Chemother; 2016 Jun; 22(6):426-9. PubMed ID: 26806150
    [Abstract] [Full Text] [Related]

  • 24. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W, Stoughton RB.
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [Abstract] [Full Text] [Related]

  • 25. Digital fluorescence photography can assess the suppressive effect of benzoyl peroxide on Propionibacterium acnes.
    Pagnoni A, Kligman AM, Kollias N, Goldberg S, Stoudemayer T.
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):710-6. PubMed ID: 10534632
    [Abstract] [Full Text] [Related]

  • 26. Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence.
    Del Rosso J.
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s2-7. PubMed ID: 18404864
    [Abstract] [Full Text] [Related]

  • 27. The impact and importance of resistance.
    Tanghetti E.
    Cutis; 2007 Jul; 80(1 Suppl):5-9. PubMed ID: 17824580
    [Abstract] [Full Text] [Related]

  • 28. The utility of benzoyl peroxide in hydrophase base (Brevoxyl) in the treatment of acne vulgaris.
    Weinberg JM.
    J Drugs Dermatol; 2006 Apr; 5(4):344-9. PubMed ID: 16673802
    [Abstract] [Full Text] [Related]

  • 29. The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach.
    Leyden JJ, Del Rosso JQ.
    J Drugs Dermatol; 2012 Jul; 11(7):830-3. PubMed ID: 22777224
    [Abstract] [Full Text] [Related]

  • 30. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH, Kim IH, Seo JJ.
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [Abstract] [Full Text] [Related]

  • 31. Comparative efficacy and safety results of two topical combination acne regimens.
    Kircik LH.
    J Drugs Dermatol; 2009 Jul; 8(7):624-30. PubMed ID: 19588638
    [Abstract] [Full Text] [Related]

  • 32. The effect of benzoyl peroxide on acne.
    Cunliffe WJ, Holland KT.
    Acta Derm Venereol; 1981 Jul; 61(3):267-9. PubMed ID: 6167116
    [Abstract] [Full Text] [Related]

  • 33. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Tanghetti E, Abramovits W, Solomon B, Loven K, Shalita A.
    J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
    [Abstract] [Full Text] [Related]

  • 34. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].
    Worret WI, Fluhr JW.
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):293-300. PubMed ID: 16638058
    [Abstract] [Full Text] [Related]

  • 35. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
    Puhvel SM.
    Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870
    [Abstract] [Full Text] [Related]

  • 36. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
    Sagransky M, Yentzer BA, Feldman SR.
    Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357
    [Abstract] [Full Text] [Related]

  • 37. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.
    Taylor GA, Shalita AR.
    Am J Clin Dermatol; 2004 Oct; 5(4):261-5. PubMed ID: 15301572
    [Abstract] [Full Text] [Related]

  • 38. Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
    Kircik L, Green L, Thiboutot D, Tanghetti E, Wilson D, Dhawan S, Parr L.
    J Drugs Dermatol; 2009 Sep; 8(9):812-8. PubMed ID: 19746673
    [Abstract] [Full Text] [Related]

  • 39. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M, Rodríguez-Ayala E, Ponce-Olivera RM, Tirado-Sánchez A, Arellano-Mendoza MI.
    Cir Cir; 2016 Sep; 84(3):190-5. PubMed ID: 26738649
    [Abstract] [Full Text] [Related]

  • 40. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.
    Leyden JJ, Preston N, Osborn C, Gottschalk RW.
    J Clin Aesthet Dermatol; 2011 May; 4(5):22-6. PubMed ID: 21607190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.